Micrornas in endometrial cancer: Recent advances and potential clinical applications

EXCLI Journal

Volumn 14, Issue , 2015, Pages 190-198

  Yanokura, Megumi ^a   Banno, Kouji ^a   Iida, Miho ^a   Irie, Haruko ^a   Umene, Kiyoko ^a   Masuda, Kenta ^a   Kobayashi, Yusuke ^a   Tominaga, Eiichiro ^a   Aoki, Daisuke ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Biomarker; Endometrial cancer; MicroRNA; OncomiR; Tumor suppressor miR

Indexed keywords

BIOLOGICAL MARKER; BORTEZOMIB; HYALURONIC ACID; LIPOSOME; MICRORNA; MICRORNA 125B; MICRORNA 152; MICRORNA 181B; MICRORNA 185; MICRORNA 210; MICRORNA 221; MICRORNA 30C; MICRORNA 324 3P; MICRORNA 423; MICRORNA 518B; MICRORNA LET7E; NANOPARTICLE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

CANCER CLASSIFICATION; CANCER INHIBITION; CANCER PROGNOSIS; CARCINOGENESIS; CARCINOGENICITY; DOWN REGULATION; DRUG SENSITIVITY; EARLY DIAGNOSIS; ENDOMETRIAL CANCER CELL LINE; ENDOMETRIOSIS; ENDOMETRIUM CANCER; EXOSOME; GENE EXPRESSION REGULATION; GENE REPLACEMENT THERAPY; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; METASTASIS; NONHUMAN; ONCOGENE; REVIEW; TUMOR INVASION; TUMOR SUPPRESSOR GENE; UPREGULATION;

EID: 84928236867     PISSN: None     EISSN: 16112156     Source Type: Journal    
DOI: 10.17179/excli2014-590     Document Type: Review

References (61)

1. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. Lancet. 2005;366:491-505.
2. Banno K, Kisu I, Yanokura M, Masuda K, Ueki A, Kobayashi Y, et al. Epigenetics and genetics in endo-metrial cancer: new carcinogenic mechanisms and relationship with clinical practice. Epigenomics. 2012; 4:147-62.
3. Bansal N, Yendluri V, Wenham RM. The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies. Cancer Control. 2009;16:8-13.
4. Boren T, Xiong Y, Hakam A, Wenham R, Apte S, Wei Z, et al. MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis. Gynecol Oncol. 2008;110:206-15.
5. Broderick JA, Zamore PD. MicroRNA therapeutics. Gene Ther. 2011;18:1104-10.
6. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A. 2002;99:15524-9.
7. Chan E, Prado DE, Weidhaas JB. Cancer microRNAs from subtype profiling to predictors of response to therapy. Trends Mol Med. 2011;17:235-43.
8. Chen C, Ridzon D, Lee CT, Blake J, Sun Y, Strauss WM. Defining embryonic stem cell identity using differentiation-related microRNAs and their potential targets. Mamm Genome. 2007;18:316-27.
9. Chen Y, Zhu X, Zhang X, Liu B, Huang L. Nanoparti-cles modified with tumor-targeting scFv deliver siR-NA and miRNA for cancer therapy. Mol Ther. 2010; 18:1650-6.
10. Chim SS, Shing TK, Hung EC, Leung TY, Lau TK, Chiu RW, et al. Detection and characterization of pla-cental microRNAs in maternal plasma. Clin Chem. 2008;54:482-90.
11. Chung TK, Cheung TH, Huen N Y, Wong KW, Lo KW, Yim SF, et al. Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women. Int J Cancer. 2009;124:1358-65.
12. Chung TK, Lau TS, Cheung TH, Yim SF, Lo KW, Siu NS, et al. Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1. Int J Cancer. 2012;130:1036-45.
13. Dai Y, Xia W, Song T, Su X, Li J, Li S, et al. Mi-croRNA-200b is overexpressed in endometrial adeno-carcinomas and enhances MMP2 activity by down-regulating TIMP2 in human endometrial cancer cell line HEC-1A cells. Nucleic Acid Ther. 2013;23:29-34.
14. Dong P, Kaneuchi M, Watari H, Hamada J, Sudo S, Ju J, et al. MicroRNA-194 inhibits epithelial to mesen-chymal transition of endometrial cancer cells by targeting oncogene BMI-1. Mol Cancer. 2011;10:99.
15. Dong P, Kaneuchi M, Watari H, Sudo S, Sakuragi N. MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endome-trial cancer cell lines. Mol Carcinog. 2014;53:349-59.
16. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001;411:494-8.
17. Fujita S, Ito T, Mizutani T, Minoguchi S, Yamamichi N, Sakurai K, et al. miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism. J Mol Biol. 2008;378:492-504.
18. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, et al. Serum microRNAs are promising novel biomarkers. PLoS One. 2008;3:e3148.
19. Gondi CS, Rao JS. Concepts in invivo siRNA delivery for cancer therapy. J Cell Physiol. 2009;220:285-91.
20. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yan-agisawa K, Tomida S, et al. A polycistronic micro-RNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. 2005;65:9628-32.
21. Hiroki E, Suzuki F, Akahira J, Nagase S, Ito K, Sugawara J, et al. MicroRNA-34b functions as a potential tumor suppressor in endometrial serous adeno-carcinoma. Int J Cancer. 2012;131:E395-404.
22. Huang YW, Liu JC, Deatherage DE, Luo J, Mutch DG, Goodfellow PJ, et al. Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancer. Cancer Res. 2009; 69:9038-46.
23. Huang YW, Kuo CT, Chen JH, Goodfellow PJ, Huang TH, Rader JS, et al. Hypermethylation of miR-203 in endometrial carcinomas. Gynecol Oncol. 2014;133: 340-5.
24. International Human Genome Sequencing Consortium: Finishing the euchromatic sequence of the human genome. Nature. 2004;431:931-45.
25. Jiang F, Liu T, He Y, Yan Q, Chen X, Wang H, et al. MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo. BMC Cancer. 2011;11:425.
26. Jiang L, Meng W, Zeng J, Hu H, Lu L. MiR-34c oli-gonucleotide enhances chemosensitivity of Ishikawa cell to cisplatin by inducing apoptosis. Cell Biol Int. 2013;37:577-83.
27. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, et al. RAS is regulated by the let-7 microRNA family. Cell. 2005;120:635-47.
28. Kong X, Xu X, Yan Y, Guo F, Li J, Hu Y, et al. Estrogen regulates the tumour suppressor MiRNA-30c and its target gene, MTA-1, in endometrial cancer. PLoS One. 2014;9:90810.
29. Kong YW, Ferland-McCollough D, Jackson TJ, Bush-ell M. microRNAs in cancer management. Lancet Oncol. 2012;13:249-58.
30. Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, Munk ME, et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science. 2010;327:198-201.
31. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins A P, Pulford K, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol. 2008;141:672-5.
32. Lee YS, Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev. 2007;21:1025-30.
33. Lee LJ, Ratner E, Uduman M, Winter K, Boeke M, Greven KM, et al. The KRAS-variant and miRNA expression in RTOG endometrial cancer clinical trials 9708 and 9905. PLoS One. 2014;9:94167.
34. Lin SL, Chang DC, Chang-Lin S, Lin CH, Wu DT, Chen DT, et al. Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. RNA. 2008;14:2115-24.
35. Liu P, Qi M, Ma C, Lao G, Liu Y, Liu Y, et al. Let7a inhibits the growth of endometrial carcinoma cells by targeting Aurora-B. FEBS Lett. 2013;587:2523-9.
36. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834-8.
37. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating mi-croRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008;105:10513-8.
38. Mozos A, Catasús L, D'Angelo E, Serrano E, Espino-sa I, Ferrer I, et al. The FOXO1-miR27 tandem regulates myometrial invasion in endometrioid endometri-al adenocarcinoma. Hum Pathol. 2014;45:942-51.
39. Olive V, Bennett MJ, Walker JC, Ma C, Jiang I, Cor-don-Cardo C, et al. miR-19 is a key oncogenic component of mir-17-92. Genes Dev. 2009;23:2839-49.
40. Osaki M, Takeshita F, Sugimoto Y, Kosaka N, Yama-moto Y, Yoshioka Y, et al. MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression. Mol Ther. 2011;19: 1123-30.
41. Randall G, Panis M, Cooper JD, Tellinghuisen TL, Sukhodolets KE, Pfeffer S, et al. Cellular cofactors affecting hepatitis C virus infection and replication. Proc Natl Acad Sci U S A 2007;104:12884-9.
42. Shang C, Lu YM, Meng LR. MicroRNA-125b down-regulation mediates endometrial cancer invasion by targeting ERBB2. Med Sci Monit. 2012;18:149-55.
43. Shen Y, Lu L, Xu J, Meng W, Qing Y, Liu Y, et al. Bortezomib induces apoptosis of endometrial cancer cells through microRNA-17-5p by targeting p21. Cell Biol Int. 2013;37:1114-21.
44. Stefani G, Slack FJ. Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol. 2008;9: 219-30.
45. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004;64:3753-6.
46. Takeshita F, Patrawala L, Osaki M, Takahashi RU, Yamamoto Y, Kosaka N, et al. Systemic delivery of synthetic microRNA-16 inhibits the growth of meta-static prostate tumors via downregulation of multiple cell-cycle genes. Mol Ther. 2010;18:181-7.
47. Tan ZQ, Liu FX, Tang HL, Su Q. Expression and its clinical significance of hsa-miR-155 in serum of en-dometrial cancer. Zhonghua Fu Chan Ke Za Zhi. 2010;45:772-4. [in Chinese].
48. Torres A, Torres K, Pesci A, Ceccarino M, Paszkow-ski T, Cassandrini P, et al. Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTor kinase in endome-trioid endometrial carcinoma. BMC Cancer. 2012;12: 369.
49. Torres A, Torres K, Pesci A, Ceccaroni M, Paszkow-ski T, Cassandrini P, et al. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients. Int J Cancer. 2013;132:1633-45.
50. Tsukamoto O, Miura K, Mishima H, Abe S, Kaneuchi M, Higashijima A, et al. Identification of endometri-oid endometrial carcinoma-associated microRNAs in tissue and plasma. Gynecol Oncol. 2014;132:715-21.
51. Tsuruta T, Kozaki K, Uesugi A, Furuta M, Hirasawa A, Imoto I, et al. miR-152 is a tumor suppressor mi-croRNA that is silenced by DNA hypermethylation in endometrial cancer. Cancer Res. 2011;71:6450-62.
52. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9:654-9.
53. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006;103:2257-61.
54. Wu W, Lin Z, Zhuang Z, Liang X. Expression profile of mammalian microRNAs in endometrioid adenocar-cinoma. Eur J Cancer Prev. 2009;18:50-5.
55. Wu Y, Xiao Y, Ding X, Zhuo Y, Ren P, Zhou C, et al. A miR-200b/200c/429-binding site polymorphism in the 30 untranslated region of the AP-2a gene is associated with cisplatin resistance. PLoS One. 2011;6: 29043.
56. Xie Y, Wang YL, Yu L, Hu Q, Ji L, Zhang Y, et al. Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells. J Steroid Bio-chem Mol Biol. 2011;126:113-20.
57. Yan GJ, Yu F, Wang B, Zhou HJ, Ge Q Y, Su J, et al. MicroRNA miR-302 inhibits the tumorigenicity of endometrial cancer cells by suppression of Cyclin D1 and CDK1. Cancer Lett. 2014;345:39-47.
58. Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong Y, et al. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell. 2007;131:1109-23.
59. Yu S, Liu Y, Wang J, Guo Z, Zhang Q, Yu F, et al. Circulating microRNA profiles as potential bi-omarkers for diagnosis of papillary thyroid carcinoma. J Clin Endocrinol Metab. 2012;97:2084-92.
60. Zhai H, Karaayvaz M, Dong P, Sakuragi N, Ju J. Prognostic significance of miR-194 in endometrial cancer. Biomark Res. 2013;1:12.
61. Zhou H, Xu X, Xun Q, Yu D, Ling J, Guo F, et al. mi-croRNA-30c negatively regulates endometrial cancer cells by targeting metastasis-associated gene-1. Oncol Rep. 2012;27:807-12.